OXB Future Development

1. Social

1.1. Community engagement

1.2. Employee activities

1.3. Social enterprise activities

1.4. Community perception

2. Technological

2.1. Big data

2.2. New vectors

2.2.1. AdV

2.2.2. AAV

2.2.3. LV

2.3. New products

2.3.1. Liver

2.3.2. Oncology

2.4. New Technologies

2.4.1. U1

2.4.2. U2

2.4.3. Pseudotypes

2.4.4. Promoters

3. Legal

3.1. Regulatory requirements

3.1.1. EMA

3.1.2. FDA

3.1.3. MHRA

3.1.4. AMED

4. Political

4.1. COVID vaccine manufacture

4.2. Organizational expansion

4.3. UK vs EU vs Global

4.4. Lobby regulatory agencies

5. Economic

5.1. Local vs UK vs EU vs global economy

5.2. CDMO vs product development

5.3. Manufacture vs pilot studies

5.4. Low-cost feasibility studies

6. Environmental

6.1. Regulation

6.2. Environmental commitment

6.3. Value-added management